Latest Breaking News On - Boo kuang loon - Page 1 : comparemela.com

2021-07-07 04:05:31 GMT2021-07-07 12:05:31(Beijing Time) Xinhua English KUALA LUMPUR, July 7 (Xinhua) Malaysian firm Yong Tai Bhd, which has partnered China-based Shenzhen Kangtai Biological Products Co. Ltd. (SZKT) to supply Chinese-produced COVID-19 vaccine in Malaysia, is targeting to offer its vaccines to private sector by September or October. Yong Tai s chief executive officer Boo Kuang Loon said the group, which has an agreement with SZKT to supply 10 million doses per year with an additional option of 10 million if required, has commenced its trial vaccination. We are currently conducting the Phase III Clinical Trial in Malaysia and have made an application to the National Pharmaceutical Regulatory Agency for approval to use the vaccines here. If everything goes smooth, we aim to obtain the approval by September or October, he told Xinhua in a recent written interview.

Kuala lumpurYong taiYong tai bhdSolution groupMyeg servicesAnhui zhifei longcom biopharmaceutical coShenzhen kangtai biological products coNational pharmaceutical regulatory agencyChinese academy of sciencesChina based shenzhen kangtai biological productsBoo kuang loonAnhui zhifei longcom biopharmaceuticalChinese academyகுவாலா லம்பூர்யோங் தையோங் தை ப்ட்